CLDN1 and cancer: Notably, claudin-1 (CLDN1) is downregulated in several cancers, and this correlates with recurrence or metastatic phenotype of lung adenocarcinoma, gastric cancer, breast cancer, melanoma, and colon cancer 22-26.